Insignis Therapeutics Receives Positive FDA Feedback on IN-001 Clinical Program for Needle-Free Anaphylaxis Treatment
November 05, 2024 08:00 ET
|
Insignis Therapeutics, Inc.
Insignis Therapeutics advances IN-001, a needle-free anaphylaxis treatment, following FDA’s positive feedback and Fast Track designation.
Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis
October 07, 2024 08:00 ET
|
Insignis Therapeutics, Inc.
Insignis' Phase 1 trial shows IN-001 spray quickly reaches target epinephrine levels, sustained for 2 hours, offering a reliable needle-free alternative.
Epinephrine Autoinjectors Industry Research Business Report 2024 Featuring ALK-Abello, Bausch + Lomb, Emerade, Teva Pharmaceutical
September 26, 2024 11:37 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Autoinjectors - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Epinephrine Auto-Injection Market Report 2024-2029: Increasing Demand at Pharma/Retail stores, Customization and Personalization, and Rise of Generic Epinephrine Auto-injectors
August 19, 2024 05:12 ET
|
Research and Markets
Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Epinephrine...
Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment
August 13, 2024 07:30 ET
|
Insignis Therapeutics, Inc.
Insignis’ liquid epinephrine sublingual spray for anaphylaxis, stable and usable under both extreme heat and cold, gains FDA Fast Track designation.
Epinephrine Market Size to Surpass USD 4.08 Billion by 2030, at a CAGR of 11.3%
November 20, 2023 06:14 ET
|
Fortune Business Insights
Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The global epinephrine market size was valued at USD 1.75 billion in 2022 and it is set to expand from USD 1.92 billion in 2023 to USD 4.08 billion by...
Epinephrine Global Market Report 2023: Market to Reach $3.49 Billion in 2027 at a CAGR of 9.4% - Long-term Forecast to 2032
November 10, 2023 04:48 ET
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Epinephrine Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global epinephrine market is expected to grow...
AAFA Joins Advocates on Capitol Hill in Support of Dillon’s Law and Expanded Access to Epinephrine
October 26, 2023 07:00 ET
|
Asthma and Allergy Foundation of America
Washington, DC, Oct. 26, 2023 (GLOBE NEWSWIRE) -- This week, the Asthma and Allergy Foundation of America (AAFA) is proud to join the unwavering advocacy efforts of Angel and George Mueller, parents...
Epinephrine Market Size to Surpass USD 3.63 Billion by 2029, exhibiting a CAGR of 11.0%
October 25, 2023 06:33 ET
|
Fortune Business Insights
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The global epinephrine market size was valued at USD 1.60 billion in 2021, and it is projected to grow from USD 1.75 billion in 2022 to USD 3.63...
Innovations and Growing Awareness Fuel Demand for Epinephrine Autoinjectors, Predicts Global Market Worth $497.25 Mn by 2027
September 14, 2023 05:13 ET
|
Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Global Epinephrine Autoinjector Market (2023-2028) by Dosage, Application, End User, and Geography, Competitive Analysis, Impact of Covid-19 and...